Zacks.com on MSN
Sweetgreen (SG) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
Beyond analysts' top-and-bottom-line estimates for Sweetgreen (SG), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ...
National Investments Company continues to build on its positive momentum, delivering sustainable financial and operational ...
TG Therapeutics, Inc. (NASDAQ: TGTX) Q3 2025 Earnings Call Transcript November 3, 2025 TG Therapeutics, Inc. beats earnings ...
Zacks Investment Research on MSN
Here's What Key Metrics Tell Us About Pfizer (PFE) Q3 Earnings
For the quarter ended September 2025, Pfizer (PFE) reported revenue of $16.65 billion, down 5.9% over the same period last year. EPS came in at $0.87, compared to $1.06 in the year-ago quarter. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback